Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (6386)	5/28/1998 4:10:00 PM
From: Starlight	Respond to of 17367

PB - Thanks for the clarification. I didn't hear the entire report on CNBC, but I did hear "sepsis" and "XOMA" mentioned.

To: Pseudo Biologist who wrote (6386)	6/1/1998 1:17:00 AM
From: aknahow	Respond to of 17367

In the real world experts say it is now, "patent or perish". XOMA certainly has an interesting portfolio of patents. Again I am impressed that this firm chose to use XOMA as an example to describe technology transfer. Pesudo, check out this site for other interesting information. tekes.fi Management of Technology Asset [ TOC \| Previous \| Next ] The Importance of Patent Portfolio Patents are often considered the most important form of intellectual property, but they only provide the frame for it. An organization also owns other knowledge property like databases and R&D reports. Furthermore, a great deal of knowledge is embodied in individuals who are developing the knowledge and in the organization's systems and processes. This knowledge should also be integrated into the process of securing intellectual property. Intellectual property rights will continue to be a global issue impacting the operations of various organizations' business behavior in various countries. The time effectiveness of patents will diminish, however, as product life cycles decrease and innovation times are reduced. An intellectual property strategy should allow the company to: 1.Continuously sell its products, especially if they are superior to its competitors 2.Earn extra revenues from the sale of technology and/or the license of intellectual property rights 3.Prepare for patent infringement claims Effective intellectual property protection strategies put the technology portfolio to maximum use, while enabling the proactive management of new technologies. This is very important since early and active patenting is key to the development of the intellectual property strategy. This is even more critical for technology-driven organizations, which need procedures that ensure the immediate recognition and protection of new, important inventions. An organization's intellectual property strategy usually becomes more sophisticated as it grows and gains experience. Fast-growing, technology-driven companies, however, often grow faster than their strategic planning capability. It is important for these companies to minimize that gap. Venture capital companies and stockholders pay attention to the value of proprietary patent positions, and they are naturally more interested in organizations that own the future's valuable technologies. The cost of acquiring and maintaining patents illustrates the importance of a well-defined intellectual property right strategy and patent budget. This is where geographical scope comes into play. Patents should be filed in countries that are major markets for the company's products, or where its competitors are located and manufacture their products. More on patenting activity can be found in the article by Kimberlie L. Cerrone and Thomas Villeneuve ,Power to the Patents How to Maximize the Value of Your Company's Technology Portfolio. Additionally, the article by Richard C. Hsu What Every Biomed Start-Up Should Know About Patents? gives a concise, profound description of what an inventor should know. The article describes the patentability of innovations, the duration of the patent application process, etc. The field of intellectual property comprises patents, trademarks, copyrights and trade secrets, all of which are intended to protect the intellectual effort of those whose creative or scientific talents can benefit us all. Patenting and licensing of intellectual property are key components of almost any successful marketing program, whether it is conducted by the Federal government or by private industry. Intellectual property is intangible property, the rights for which can be bought and sold, leased or rented, or otherwise transferred between parties in much the same way that real estate or other personal property can be transferred. Various cases have been written describing scientists' success in turning their patented discoveries into lucrative commercial deals worth several times their funding from other sources. This funding has become increasingly crucial as federal government support for biomedical research has decreased. Despite this increased activity, however, scientists insist that the developing of a patentable innovation has not become a driving factor in their research strategies. These accounts are said to be rare exceptions rather than the rule. A well-run laboratory cannot be built upon these kind of patent successes, even though they provide extra funding. Instead, published research and steady grant support remains the key to a secure future in basic science, as it has been for many decades. The success of various patented innovations, however, has changed the axiom in biotechnology from "publish or perish" to "patent or perish." [ TOC \| Previous \| Next ]